Safety, Pharmacokinetics (PK) of AKT and MEK Combination

NCT01138085 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer

Interventions

DRUG: GSK1120212
DRUG: GSK2141795

Sponsor

GlaxoSmithKline